Trivago shares have been rallying strongly in recent weeks along with other travel-related companies on hopes about an end to the COVID-19 pandemic. Pharmaceutical and biotech companies have been announcing progress on three separate vaccine candidates that have demonstrated encouraging effectiveness in early trials.